The Race of CAR Therapies: CAR-NK Cells for Fighting B-Cell Hematological Cancers

Acute lymphoblastic leukemia (ALL) and Chronic lymphocytic leukemia (CLL) are the most common leukemias in children and elderly people, respectively. Standard therapies, such as chemotherapy, are only effective in 40% of ALL adult patients with a five-year survival rate and therefore new alternative...

Full description

Saved in:
Bibliographic Details
Main Authors: Lara Herrera, Silvia Santos, Miguel Angel Vesga, Tomas Carrascosa, Juan Carlos Garcia-Ruiz, Antonio Pérez-Martínez, Manel Juan, Cristina Eguizabal
Format: article
Language:EN
Published: MDPI AG 2021
Subjects:
Online Access:https://doaj.org/article/4ba5c4420bbb41e9b71bdae59fe70e56
Tags: Add Tag
No Tags, Be the first to tag this record!